These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37409524)

  • 1. Conformational response to ligand binding of TMPRSS2, a protease involved in SARS-CoV-2 infection: Insights through computational modeling.
    Frumenzio G; Chandramouli B; Besker N; Grottesi A; Talarico C; Frigerio F; Emerson A; Musiani F
    Proteins; 2023 Sep; 91(9):1288-1297. PubMed ID: 37409524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Transmembrane Protease Serine 2 (TMPRSS2) Non-Protease Domains Regulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike-Mediated Virus Entry.
    Strobelt R; Adler J; Shaul Y
    Viruses; 2023 Oct; 15(10):. PubMed ID: 37896901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and activity of human TMPRSS2 protease implicated in SARS-CoV-2 activation.
    Fraser BJ; Beldar S; Seitova A; Hutchinson A; Mannar D; Li Y; Kwon D; Tan R; Wilson RP; Leopold K; Subramaniam S; Halabelian L; Arrowsmith CH; Bénard F
    Nat Chem Biol; 2022 Sep; 18(9):963-971. PubMed ID: 35676539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
    Li K; Meyerholz DK; Bartlett JA; McCray PB
    mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
    Essalmani R; Jain J; Susan-Resiga D; Andréo U; Evagelidis A; Derbali RM; Huynh DN; Dallaire F; Laporte M; Delpal A; Sutto-Ortiz P; Coutard B; Mapa C; Wilcoxen K; Decroly E; Nq Pham T; Cohen ÉA; Seidah NG
    J Virol; 2022 Apr; 96(8):e0012822. PubMed ID: 35343766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of SARS-CoV-2 Spike Mutations on Its Activation by TMPRSS2 and the Alternative TMPRSS13 Protease.
    Stevaert A; Van Berwaer R; Mestdagh C; Vandeput J; Vanstreels E; Raeymaekers V; Laporte M; Naesens L
    mBio; 2022 Aug; 13(4):e0137622. PubMed ID: 35913162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metalloproteinase-Dependent and TMPRSS2-Independent Cell Surface Entry Pathway of SARS-CoV-2 Requires the Furin Cleavage Site and the S2 Domain of Spike Protein.
    Yamamoto M; Gohda J; Kobayashi A; Tomita K; Hirayama Y; Koshikawa N; Seiki M; Semba K; Akiyama T; Kawaguchi Y; Inoue JI
    mBio; 2022 Aug; 13(4):e0051922. PubMed ID: 35708281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular docking analysis reveals the functional inhibitory effect of Genistein and Quercetin on TMPRSS2: SARS-COV-2 cell entry facilitator spike protein.
    Manjunathan R; Periyaswami V; Mitra K; Rosita AS; Pandya M; Selvaraj J; Ravi L; Devarajan N; Doble M
    BMC Bioinformatics; 2022 May; 23(1):180. PubMed ID: 35578172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving Soluble Expression of SARS-CoV-2 Spike Priming Protease TMPRSS2 with an Artificial Fusing Protein.
    Ye X; Ling X; Wu M; Bai G; Yuan M; Rao L
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the intestinal TMPRSS2 protease to prevent SARS-CoV-2 entry into enterocytes-prospects and challenges.
    Mahmoud IS; Jarrar YB
    Mol Biol Rep; 2021 May; 48(5):4667-4675. PubMed ID: 34023987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Native and activated antithrombin inhibits TMPRSS2 activity and SARS-CoV-2 infection.
    Wettstein L; Immenschuh P; Weil T; Conzelmann C; Almeida-Hernández Y; Hoffmann M; Kempf A; Nehlmeier I; Lotke R; Petersen M; Stenger S; Kirchhoff F; Sauter D; Pöhlmann S; Sanchez-Garcia E; Münch J
    J Med Virol; 2023 Jan; 95(1):e28124. PubMed ID: 36056630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Basis of Covalent Inhibitory Mechanism of TMPRSS2-Related Serine Proteases by Camostat.
    Sun G; Sui Y; Zhou Y; Ya J; Yuan C; Jiang L; Huang M
    J Virol; 2021 Sep; 95(19):e0086121. PubMed ID: 34160253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmembrane serine protease TMPRSS2 implicated in SARS-CoV-2 infection is autoactivated intracellularly and requires N-glycosylation for regulation.
    Zhang Y; Sun S; Du C; Hu K; Zhang C; Liu M; Wu Q; Dong N
    J Biol Chem; 2022 Dec; 298(12):102643. PubMed ID: 36309092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactive Centre Loop Mutagenesis of SerpinB3 to Target TMPRSS2 and Furin: Inhibition of SARS-CoV-2 Cell Entry and Replication.
    Singh S; O'Reilly S; Gewaid H; Bowie AG; Gautier V; Worrall DM
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting mechanism for SARS-CoV-2
    Zhao X; Luo S; Huang K; Xiong D; Zhang JZH; Duan L
    Nanoscale; 2021 Nov; 13(45):19218-19237. PubMed ID: 34787160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Interactions of Tannic Acid with Proteins Associated with SARS-CoV-2 Infectivity.
    Haddad M; Gaudreault R; Sasseville G; Nguyen PT; Wiebe H; Van De Ven T; Bourgault S; Mousseau N; Ramassamy C
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spiking dependence of SARS-CoV-2 pathogenicity on TMPRSS2.
    Abbasi AZ; Kiyani DA; Hamid SM; Saalim M; Fahim A; Jalal N
    J Med Virol; 2021 Jul; 93(7):4205-4218. PubMed ID: 33638460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual Inhibition of Vacuolar-ATPase and TMPRSS2 Is Required for Complete Blockade of SARS-CoV-2 Entry into Cells.
    Icho S; Rujas E; Muthuraman K; Tam J; Liang H; Landreth S; Liao M; Falzarano D; Julien JP; Melnyk RA
    Antimicrob Agents Chemother; 2022 Jul; 66(7):e0043922. PubMed ID: 35703551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A substrate for a cell free in vitro assay system to screen drugs targeting trypsin like protease-based cleavage of SARS-CoV-2 spike glycoprotein and viral entry.
    Begum F; Srivastava AK; Tripathi PP; Ray U
    J Med Virol; 2023 May; 95(5):e28796. PubMed ID: 37218551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways.
    Laporte M; Raeymaekers V; Van Berwaer R; Vandeput J; Marchand-Casas I; Thibaut HJ; Van Looveren D; Martens K; Hoffmann M; Maes P; Pöhlmann S; Naesens L; Stevaert A
    PLoS Pathog; 2021 Apr; 17(4):e1009500. PubMed ID: 33886690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.